SharmaJC: Non-neurological variables and mortality of acute stroke. Int J Clin Pract2001; 55: 619–26.
2.
WarlowCWardlawJ: Therapeutic thrombolysis for acute ischemic stroke. BMJ2003; 326: 233–4.
3.
LeesKRZivinJAAshwoodT. Stroke-acute ischemic NXY treatment (SAINT I) trial investigators. N Eng J Med2006; 354: 588–600.
4.
VahediKHofmeijerJJuettlerE. DECIMAL, DESTINY, and HAMLET investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials. Lancet Neurol2007; 6: 215–22.
5.
ChenZMSandercockPPanHC. Indications for early aspirin use in acute ischaemic stroke: A combined analysis of 40,000 randomised patients from the Chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke2000; 31: 1240–9.
6.
MillanMDavalosA: The need for new therapies for acute ischaemic stroke. Cerebrovasc Dis2006; 22(Suppl. 1): 3–9.
7.
SharmaJCFletcherSVassalloMRossIN: Cardiovascular disease and outcome of acute stroke: Influence of pre-existing cardiac failure. Eur J Heart Fail2000; 2: 145–50.
8.
AppelrosPNydevikISeigerATerentA: Predictors of severe stroke: Influence of pre-existing dementia and cardiac disorders. Stroke2002; 33: 2357–62.
9.
EtgenTBaumHSanderKSanderD: Cardiac troponin and N-terminal pro-brain natriuretic peptide in acute ischaemic stroke do not relate to clinical prognosis. Stroke2005; 36: 270–5.
10.
NakagawaKYamaguchiTSeidaM. Plasma concentration of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis2005; 19: 157–64.
11.
JamesPEllisCJWhitlockRMLMcNeilARHenleyJAndersonNE: Relation between troponin T concentration and mortality in patients with an acute stroke: Observational study. BMJ2000; 320: 1502–4.
12.
MakikallioAMMakikallioTHKorpelainenJT. Natriuretic peptides and mortality after stroke. Stroke2005; 36: 1016–20.
13.
SharmaJCAnandaKRossIHillRVassalloM: N-terminal proBrain natriuretic peptide levels predict short term post stroke survival. J Stroke Cerebrovasc Dis2006; 15: 121–7.
14.
JensenJKMickleyHBakSKorsholmLKristensenSR: Serial measurement of N-Terminal pro-Brain natriuretic peptide after acute ischaemic stroke. Cerebrovasc Dis2006; 22: 439–44.
15.
LehmanRDoustJGlasziouP: Cardiac impairment or heart failure?BMJ2005; 331: 415–6.
16.
BareDHCruickshankJMEbrahimSBMitchellJR: Lowdosebetablock-ade in acute stroke (BEST trial): An evaluation. BMJ1988; 296: 737–41.
17.
SchraderJLudersS. On behalf of ACCESS Study Group The ACCESS study: Evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke2003; 34: 1699.
